AlMuhid has been at the helm of SCCH since 2020. The group’s subsidiaries include SITCO Pharma, AJA Pharma, the Suez International Nitrate Company, the Saudi Chemical Company Limited, and the Chemical Commercial Investment Company. SCCH recorded assets of $1.5 billion and revenues of $438.6 million, as of March 2024. AJA Pharma completed recently the certification process of its newest sterile line with the Saudi FDA to manufacture biosimilars. The Saudi Chemical Company Limited established a new production facility dedicated to the production of ammonium nitrate and nitric acid in Ras Al Khair. AlMuhid previously held roles at Almarai, the Ministry of Commerce and Industry, and SABIC